Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Clasificación en acciones #2525
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Precio por acción
$100.24
Capitalización bursátil
$7.51B
Cambio (1 día)
-1.84%
Cambio (1 año)
48.99%
País
CH
Comercio Bachem Holding AG (BANB)

Categoría

Healthcare
Historial del precio de la acción de Bachem Holding AG (BANB)
Precio más alto de cierre: $105.12 el 2026-10-01

Precio más bajo de cierre: $13.47 el 2001-03-01
Historial del precio de la acción de Bachem Holding AG desde 2001 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 26.87%
2025 -3.05%
2024 -5.47%
2023 -16.69%
2022 -35.59%
2021 68.81%
2020 169.92%
2019 28.96%
2018 -16.46%
2017 68.14%
2016 64.94%
2015 3.94%
2014 -8.15%
2013 45.10%
2012 -0.04%
2011 -34.01%
2010 -12.09%
2009 -5.58%
2008 -20.36%
2007 13.73%
2006 32.09%
2005 1.28%
2004 12.61%
2003 11.00%
2002 -19.59%
2001 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$535.81 25.65%
US
$188.41 601.69%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$890.95 9.43%
NL